Therapeutic effect of Peg-IFN therapy combined with RBV and telaprevir(TVR) on patients with chronic hepatitis C
Not Applicable
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000013743
- Lead Sponsor
- Division of digestive and lifestyle disease, Kagoshima university graduate school of medical and dental sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not fulfill the criteria to receive the approved Peg-IFN-alpha2b/RBV/telaprevir treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sustained virologic response rate
- Secondary Outcome Measures
Name Time Method